These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32498128)

  • 21. Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic.
    Reynolds SD; Mathur AN; Chiu YE; Brandling-Bennett HA; Pope E; Siegel MP; Holland KE; Paller AS; Siegfried EC; Tom WL; Lara-Corrales I; Tollefson MM; Maguiness S; Eichenfield LF; Sugarman J; Frieden IJ; Oza VS; Cipriano SD; Huang JT; Shah SD; Lauren CT; Castelo-Soccio L; McMahon P; Cordoro KM
    Pediatr Dermatol; 2020 May; 37(3):424-434. PubMed ID: 32320494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes.
    Chernyshov PV; Evers AWM; Bewley A; Tomas-Aragones L; Marron SE; Manolache L; Pustišek N; Abeni D; Sampogna F; Linder MD; Salek MS; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):20-23. PubMed ID: 34687091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modifications to dermatology residency education during the COVID-19 pandemic.
    Mufti A; Maliyar K; Sachdeva M; Doiron P
    J Am Acad Dermatol; 2020 Sep; 83(3):e235-e236. PubMed ID: 32497696
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts.
    Chernyshov PV; Tomas-Aragones L; Manolache L; Pustisek N; Salavastru CM; Marron SE; Bewley A; Svensson A; Poot F; Suru A; Salek SS; Augustin M; Szepietowski JС; Koumaki D; Katoulis AC; Sampogna F; Abeni D; Linder DM; Speeckaert R; van Geel N; Seneschal J; Ezzedine K; Finlay AY
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):21-31. PubMed ID: 36259656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic.
    Villani A; Annunziata MC; Abategiovanni L; Fabbrocini G
    J Cosmet Dermatol; 2020 Aug; 19(8):1828. PubMed ID: 32490578
    [No Abstract]   [Full Text] [Related]  

  • 26. Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy).
    Atzori L; Mugheddu C; Addis G; Sanna S; Satta R; Ferreli C; Atzori MG; Montesu MA; Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e247-e248. PubMed ID: 32294265
    [No Abstract]   [Full Text] [Related]  

  • 27. [What can we learn from the COVID-19 pandemic in general and about ourselves as dermatologists?].
    Kluger N
    Ann Dermatol Venereol; 2020; 147(6-7):413-417. PubMed ID: 32414508
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of the dermatologist in the immune-mediated/allergic diseases - position statement of the EADV task force on contact dermatitis, EADV task force on occupational skin diseases, UEMS-EBDV subcommission allergology and European Dermatology Forum.
    Balato A; Raimondo A; Arenberger P; Bruze M; Czarnecka-Operacz M; Johanssen JD; Gonçalo M; Ranki A; Uter W; Wilkinson M; Ayala F; John SM; Giménez-Arnau A; Gollnick H
    J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1459-1464. PubMed ID: 31062452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges of COVID-19 pandemic: Dermatologist's perspective from Nepal.
    Marahatta S; Marahatta SB
    Int J Dermatol; 2020 Dec; 59(12):1537-1538. PubMed ID: 33040346
    [No Abstract]   [Full Text] [Related]  

  • 30. Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?
    Shanshal M
    J Drugs Dermatol; 2020 Apr; 19(4):436. PubMed ID: 32401460
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk assessment of outpatient dermatology practice in the setting of the COVID-19 pandemic.
    Gerami P; Liszewski W
    J Am Acad Dermatol; 2020 Nov; 83(5):1538-1539. PubMed ID: 32682892
    [No Abstract]   [Full Text] [Related]  

  • 32. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer.
    Chernyshov PV; Lallas A; Tomas-Aragones L; Arenbergerova M; Samimi M; Manolache L; Svensson A; Marron SE; Sampogna F; Spillekom-vanKoulil S; Bewley A; Forsea AM; Jemec GB; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):816-827. PubMed ID: 30963614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fighting COVID-19: Early teledermatology lessons learned.
    McGee JS; Reynolds RV; Olbricht SM
    J Am Acad Dermatol; 2020 Oct; 83(4):1224-1225. PubMed ID: 32553677
    [No Abstract]   [Full Text] [Related]  

  • 34. Inpatient teledermatology during the COVID-19 pandemic.
    Rismiller K; Cartron AM; Trinidad JCL
    J Dermatolog Treat; 2020 Aug; 31(5):441-443. PubMed ID: 32364809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and its implications for Dermatology and Venereology.
    Ring J
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):914. PubMed ID: 32441430
    [No Abstract]   [Full Text] [Related]  

  • 36. Changing paradigms of dermatology practice in developing nations in the shadow of COVID-19: Lessons learnt from the pandemic.
    Kumar S; Bishnoi A; Vinay K
    Dermatol Ther; 2020 Jul; 33(4):e13472. PubMed ID: 32347612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Socioeconomic Changes due to the COVID-19 Pandemic With Health Outcomes in Patients With Skin Diseases: Cross-Sectional Survey Study.
    Guo Y; Shen M; Zhang X; Xiao Y; Zhao S; Yin M; Bu W; Wang Y; Chen X; Su J
    J Med Internet Res; 2020 Sep; 22(9):e22288. PubMed ID: 32845850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.
    Sadoughifar R; Goldust M; Kroumpouzos G; Szepietowski JC; Lotti T; Sandhu S
    Dermatol Ther; 2020 Jul; 33(4):e13562. PubMed ID: 32396251
    [No Abstract]   [Full Text] [Related]  

  • 39. COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment.
    Desai SR; Kovarik C; Brod B; James W; Fitzgerald ME; Preston A; Hruza GJ
    J Am Acad Dermatol; 2020 Aug; 83(2):675-677. PubMed ID: 32416206
    [No Abstract]   [Full Text] [Related]  

  • 40. Balancing aesthetic and conventional dermatology practice in the COVID-19 era.
    Arora G; Jafferany M; Arora S
    Dermatol Ther; 2020 Jul; 33(4):e13620. PubMed ID: 32431094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.